Selected Publications

Ghilardi G, Fraietta JA, Gerson J, Caponetti GC, Paruzzo L, Harris JC, Susanibar S, Svoboda J, Chong EA, Nasta SD, Ugwuanyi O, Landsburg DJ, Fardella E, Waxman A, Patel V, Pajarillo R, Cohen AD, Levine BL, Stadtmauer EA, Frey NV, Vogl DT, Barta SK, Van Deerlin V, Morrissette JJD, Porter DL, Garfall AL, Schuster SJ, June CH, and Ruella M. : "T-cell Lymphoma and Secondary Malignancy Risk After Commercial Chimeric Antigen Receptor T-cell Immunotherapy: the Penn Experience" Nature Medicine 2024 Notes: 2024, In press.

Zainul S. Hasanali, Beatrice Razzo, Sandra P. Susanibar-Adaniya, Alfred L. Garfall, Edward A. Stadtmauer, Adam D. Cohen.: Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma. Hematology/Oncology Clinics of North America Dec 2023.

Xinhe Shan, Qi Long, Alfred L. Garfall & Sandra P. Susanibar-Adaniya: High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma. Blood Cancer Journal 13(1): 86, May 2023.

Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya, Wei-Ting Hwang, Dan T. Vogl, Adam J. Waxman, Simon F. Lacey, Vanessa E. Gonzalez, Joseph A. Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L. Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Don L. Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V. Wilson, Fei Miao, Eric Lancaster, Beatriz M. Carreno, Gerald P. Linette, Elizabeth O. Hexner, Regina M. Young, Dexiu Bu, Keith G. Mansfield, Jennifer L. Brogdon, Carl H. June, Michael C. Milone, Edward A. Stadtmauer: Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood Cancer Discovery 4(2): 118-133, Mar 2023.

Brian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, Sandra P Susanibar-Adaniya, Dan T Vogl, Adam J Waxman, Mark Bardsley, Samantha Le, Lexis LaMaestra, Alfred L Garfall: Progressive multifocal leukoencephalopathy in multiple myeloma. European Journal of Hematology 110(3): 322-329, Mar 2023.

Susanibar Adaniya S, Stadtmauer EA, Cohen AD.: CAR T cell therapy for multiple myeloma: What have we learned? Leukemia 36(6): 1481-1484, Jun 2022.

Garfall A, Cohen A, Stadtmauer E, Susanibar-Adaniya S, Vogl D, Waxman A.: Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy. J Clin Oncol 40(1): 106-107, Jan 2022.

Quinn, Ghazal Z., Susanibar-Adaniya, Sandra, Lau, Stacey, Kallem, Radhakrishna Reddy, Hogan, Jonathan.: Baseline Characteristics of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits in the International Kidney Registry Consortium (K-REG). American Society of Nephrology, Kidney Week, Virtual Nov 2021 Notes: "Poster Presentation"

Susanibar-Adaniya S, Barta SK.: 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management. Am J Hematol 96(5): 617-629, May 2021.

Susanibar-Adaniya S., Cummins C.L., Baroja M.L., Carreno B, Linette G.P., Garfall A.L. : Immune control of plasma cell disorders – in-depth analysis of Sox2 immunity in MGUS. Translational Science - Virtual Meeting 2020 Notes: "Oral Presentation"